DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population.

Xiaopeng ZhuJing TangHuandong LinXinxia ChangMingfeng XiaLiu WangHongmei YanHua BianXin Gao

Published in: Biomedical engineering online (2020)

DS21 is fast, noninvasive, low cost, reliable and safe, which makes it a feasible device for screening for prediabetes and diabetes, especially in a large population.

Keyphrases

low cost
type diabetes
cardiovascular disease
glycemic control
metabolic syndrome
adipose tissue